To the best of our knowledge, this is the first exploratory study to suggest and validate TOP2A as a potential prognostic biomarker in SCCE using an integrative approach that combines bioinformatics analysis and experimental validation. The gene discussed is TOP2A; the disease is cervical small cell carcinoma.